NIAID Offering $10.3M for Pathogen Dx, Therapeutics | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to grant up to $10.3 million in fiscal 2010 to fund research partnerships focused on developing diagnostics and therapeutics for drug-resistant bacteria and eukaryotic parasites.

NIAID will fund a range of research approaches for NIAID Category A, B, or C bacteria or eukaryotic parasites, as well as development of diagnostics or therapeutics against non-listed organisms for which naturally-occurring drug resistance is a growing clinical problem.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.